Search Results - Asfar S. Azmi

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Providing activation-induced cytidine deaminase (AID) to nuclear export inhibitors. Response to: “Complex downstream effects of nuclear export inhibition in B-cell lymphomas: a pos... by Asfar S. Azmi, Ramzi M. Mohammad

    Published in Haematologica (2013-09-01)
    Get full text
    Article


  2. 2

    Selective inhibitors of nuclear export for the treatment of non-Hodgkin’s lymphomas by Asfar S. Azmi, Ayad Al-Katib, Amro Aboukameel, Dilara McCauley, Michael Kauffman, Sharon Shacham, Ramzi M. Mohammad

    Published in Haematologica (2013-07-01)
    Get full text
    Article


  3. 3

    Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination by Amr Mohamed, Asfar S. Azmi, Sylvia L. Asa, Sree Harsha Tirumani, Amit Mahipal, Sakti Cjakrabarti, David Bajor, J. Eva Selfridge, Ahmed O. Kaseb

    Published in Current Oncology (2022-11-01)
    Get full text
    Article


  4. 4

    Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. by Zhiwei Wang, Sanjeev Banerjee, Aamir Ahmad, Yiwei Li, Asfar S Azmi, Jason R Gunn, Dejuan Kong, Bin Bao, Shadan Ali, Jiankun Gao, Ramzi M Mohammad, Lucio Miele, Murray Korc, Fazlul H Sarkar

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  5. 5

    Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection by Abdelrahim Maen, Abdelrahim Maen, Abdelrahim Maen, Betul Gok Yavuz, Yehia I. Mohamed, Abdullah Esmail, Jianming Lu, Amr Mohamed, Asfar S. Azmi, Mohamed Kaseb, Osama Kasseb, Dan Li, Michelle Gocio, Mehmet Kocak, Abdelhafez Selim, Qing Ma, Ahmed O. Kaseb

    Published in Frontiers in Pharmacology (2024-02-01)
    Get full text
    Article


  6. 6

    Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model by Md. Hafiz Uddin, Mohammad Najeeb Al‐Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F. Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M. Mohammad, Philip A. Philip, Anthony F. Shields, Asfar S. Azmi

    Published in Clinical and Translational Medicine (2023-12-01)
    Get full text
    Article


  7. 7

    ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma by Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, Julienne L. Carstens, Jeremy B. Foote, Emily C. Graff, Yu-Hua D Fang, Adam B. Keeton, Xi Chen, Jacob Valiyaveettil, Kristy L. Berry, Sejong Bae, Mehmet Akce, Greg Gorman, Karina J. Yoon, Upender Manne, Michael R. Boyd, Donald J. Buchsbaum, Asfar S. Azmi, Yulia Y. Maxuitenko, Gary A. Piazza, Bassel F. El-Rayes

    Published in Molecular Cancer (2025-03-01)
    Get full text
    Article


Search Tools: